CN115397469A - 粘合剂 - Google Patents

粘合剂 Download PDF

Info

Publication number
CN115397469A
CN115397469A CN202180027692.7A CN202180027692A CN115397469A CN 115397469 A CN115397469 A CN 115397469A CN 202180027692 A CN202180027692 A CN 202180027692A CN 115397469 A CN115397469 A CN 115397469A
Authority
CN
China
Prior art keywords
mass
based polymer
pva
polyvinyl alcohol
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180027692.7A
Other languages
English (en)
Chinese (zh)
Inventor
川田章太郎
河西将利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Warm & Perbar Corp
Original Assignee
Japan Warm & Perbar Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Warm & Perbar Corp filed Critical Japan Warm & Perbar Corp
Publication of CN115397469A publication Critical patent/CN115397469A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L29/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers
    • C08L29/02—Homopolymers or copolymers of unsaturated alcohols
    • C08L29/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
CN202180027692.7A 2020-04-10 2021-03-24 粘合剂 Pending CN115397469A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020071295 2020-04-10
JP2020-071295 2020-04-10
PCT/JP2021/012432 WO2021205886A1 (ja) 2020-04-10 2021-03-24 結合剤

Publications (1)

Publication Number Publication Date
CN115397469A true CN115397469A (zh) 2022-11-25

Family

ID=78022926

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180027692.7A Pending CN115397469A (zh) 2020-04-10 2021-03-24 粘合剂

Country Status (5)

Country Link
US (1) US20230148062A1 (https=)
EP (1) EP4134103A4 (https=)
JP (1) JPWO2021205886A1 (https=)
CN (1) CN115397469A (https=)
WO (1) WO2021205886A1 (https=)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191609A (ja) * 1985-02-20 1986-08-26 Bio Materiaru Yunibaasu:Kk 徐放性製剤
US5532274A (en) * 1991-01-23 1996-07-02 Isis Pharma Gmbh Orally administerable drugs for the treatment of central dopamine deficiency conditions
JP2003267889A (ja) * 2002-03-15 2003-09-25 Otsuka Pharmaceut Co Ltd 持続性医薬製剤
KR20090120538A (ko) * 2008-05-20 2009-11-25 영남대학교 산학협력단 약물전달시스템용 폴리비닐알코올 입자 및 이의 제조방법
CN104644581A (zh) * 2013-11-15 2015-05-27 信越化学工业株式会社 粒状复合物、速释片及其制备方法
WO2016013675A1 (ja) * 2014-07-25 2016-01-28 日本合成化学工業株式会社 ポリビニルアルコール微粒子、それを用いた医薬用結合剤、医薬錠剤、徐放性医薬錠剤及びポリビニルアルコール微粒子の製造方法
CN106414511A (zh) * 2014-05-28 2017-02-15 日本瓦姆&珀巴尔株式会社 悬浮聚合用分散稳定剂、乙烯基系聚合物的制造方法及氯乙烯树脂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6695013B1 (ja) * 2018-11-13 2020-05-20 日本酢ビ・ポバール株式会社 結合剤

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191609A (ja) * 1985-02-20 1986-08-26 Bio Materiaru Yunibaasu:Kk 徐放性製剤
US5532274A (en) * 1991-01-23 1996-07-02 Isis Pharma Gmbh Orally administerable drugs for the treatment of central dopamine deficiency conditions
JP2003267889A (ja) * 2002-03-15 2003-09-25 Otsuka Pharmaceut Co Ltd 持続性医薬製剤
KR20090120538A (ko) * 2008-05-20 2009-11-25 영남대학교 산학협력단 약물전달시스템용 폴리비닐알코올 입자 및 이의 제조방법
CN104644581A (zh) * 2013-11-15 2015-05-27 信越化学工业株式会社 粒状复合物、速释片及其制备方法
CN106414511A (zh) * 2014-05-28 2017-02-15 日本瓦姆&珀巴尔株式会社 悬浮聚合用分散稳定剂、乙烯基系聚合物的制造方法及氯乙烯树脂
WO2016013675A1 (ja) * 2014-07-25 2016-01-28 日本合成化学工業株式会社 ポリビニルアルコール微粒子、それを用いた医薬用結合剤、医薬錠剤、徐放性医薬錠剤及びポリビニルアルコール微粒子の製造方法
US20170209377A1 (en) * 2014-07-25 2017-07-27 The Nippon Synthetic Chemical Industry Co., Ltd. Polyvinyl alcohol particles, pharmaceutical binder using same, pharmaceutical tablet, sustained-release pharmaceutical tablet, and method for producing polyvinyl alcohol particles

Also Published As

Publication number Publication date
WO2021205886A1 (ja) 2021-10-14
JPWO2021205886A1 (https=) 2021-10-14
EP4134103A1 (en) 2023-02-15
US20230148062A1 (en) 2023-05-11
EP4134103A4 (en) 2024-04-24

Similar Documents

Publication Publication Date Title
US11723872B2 (en) Granulated composite, rapid release tablet and method for producing same
JP5788056B2 (ja) 低置換度ヒドロキシプロピルセルロース水分散液を用いた湿式造粒打錠法
KR102011518B1 (ko) 저치환도 히드록시프로필셀룰로오스를 포함하는 복합 조립물의 제조 방법 및 속방성 제제
WO2016013675A1 (ja) ポリビニルアルコール微粒子、それを用いた医薬用結合剤、医薬錠剤、徐放性医薬錠剤及びポリビニルアルコール微粒子の製造方法
JP6688756B2 (ja) 溶状に優れたヒプロメロース酢酸エステルコハク酸エステル粉末及びその製造方法、並びに固体分散体用組成物、コーティング用組成物、薬物含有粒子及び固形製剤の各製造方法
JP7379263B2 (ja) 結合剤
JP7238509B2 (ja) 医薬錠剤
US12378398B2 (en) Binder
CN115397469A (zh) 粘合剂
JP2017178857A (ja) 口腔内粘膜付着錠及びその製造方法
JP7629909B2 (ja) 徐放性基剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20221125